Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
SMSPHARMA Stoklara Genel Bakış
SMS Pharmaceuticals Limited, Hindistan'da ve uluslararası alanda aktif farmasötik bileşenler (API'ler) ve ara ürünler üretmekte ve satmaktadır.
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 0/6 |
| Gelecekteki Büyüme | 0/6 |
| Geçmiş Performans | 4/6 |
| Finansal Sağlık | 3/6 |
| Temettüler | 0/6 |
SMS Pharmaceuticals Limited Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | ₹374.25 |
| 52 Haftanın En Yüksek Seviyesi | ₹398.00 |
| 52 Haftanın En Düşük Seviyesi | ₹111.85 |
| Beta | 1.26 |
| 11 Aylık Değişim | 12.20% |
| 3 Aylık Değişim | 53.04% |
| 1 Yıllık Değişim | 204.02% |
| 33 Yıllık Değişim | 143.34% |
| 5 Yıllık Değişim | 802.90% |
| Halka arzdan bu yana değişim | 941.75% |
Son Haberler & Güncellemeler
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Sep 07
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%
Aug 20Recent updates
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Sep 07SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40
Aug 22Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%
Aug 20SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40
Aug 08What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You
Jul 04Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly
Jun 21SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18Hissedar Getirileri
| SMSPHARMA | IN Pharmaceuticals | IN Pazar | |
|---|---|---|---|
| 7D | 4.5% | 0.2% | -0.3% |
| 1Y | 204.0% | 59.4% | 44.6% |
Getiri vs. Endüstri: SMSPHARMA exceeded the Indian Pharmaceuticals industry which returned 59.4% over the past year.
Getiri vs Piyasa: SMSPHARMA exceeded the Indian Market which returned 44.6% over the past year.
Fiyat Oynaklığı
| SMSPHARMA volatility | |
|---|---|
| SMSPHARMA Average Weekly Movement | 8.4% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 3.9% |
İstikrarlı Hisse Senedi Fiyatı: SMSPHARMA's share price has been volatile over the past 3 months.
Zaman İçindeki Volatilite: SMSPHARMA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1987 | 1,197 | Ramesh Potluri | smspharma.com |
SMS Pharmaceuticals Limited, Hindistan'da ve uluslararası alanda aktif farmasötik bileşenler (API'ler) ve ara ürünler üretmekte ve satmaktadır. Şirket anti-retroviral, anti-enflamatuar, anti-viral, anti-diyabetik, anti-fungal, anti-epileptik, anti-migren, anti-koagülan, anti-psikotik, anti-aginal ve anti-ülser ürünleri sunmaktadır. Ayrıca peptitler üzerine sözleşmeli araştırma faaliyetlerinde de bulunmaktadır.
SMS Pharmaceuticals Limited Temel Bilgiler Özeti
| SMSPHARMA temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | ₹31.68b |
| Kazançlar(TTM) | ₹569.64m |
| Gelir(TTM) | ₹7.38b |
55.6x
F/K Oranı4.3x
P/S OranıSMSPHARMA aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| SMSPHARMA gelir tablosu (TTM) | |
|---|---|
| Gelir | ₹7.38b |
| Gelir Maliyeti | ₹5.16b |
| Brüt Kâr | ₹2.22b |
| Diğer Giderler | ₹1.65b |
| Kazançlar | ₹569.64m |
Son Raporlanan Kazançlar
Jun 30, 2024
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | 6.73 |
| Brüt Marj | 30.12% |
| Net Kâr Marjı | 7.71% |
| Borç/Özkaynak Oranı | 52.4% |
SMSPHARMA uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görün